Eye-catching experiment reduces rudeness in operating theaters

Australian researchers have successfully trialed a novel experiment to address offensive and rude comments in operating theatres by placing ‘eye’ signage in surgical rooms.

Kinder, Gentler Regimen for Classical Hodgkin Prevails in Randomized Trial

CHICAGO — Replacing chemotherapy with a targeted agent resulted in a better tolerated regimen for advanced classical Hodgkin lymphoma (cHL) with no loss in efficacy,

June 2, 2024

Editas sells future CRISPR license fees; Plus, news about Oncolytics Biotech

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 5, 2024

Exact Sciences reports initial positive results in colon cancer blood test, but pivot trial still pending

Exact Sciences, which has for years sold a stool-based colon cancer test, on Monday announced that a blood-based test it’s developing showed promise in accurately

September 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.